Skip to content

A study on the reliability and validity of Colombia Muscle Cramp Scale(CMCS) in Amyotrophic Lateral Sclerosis patients with painful muscle cramps

A study on the reliability and validity of Colombia Muscle Cramp Scale(CMCS) in Amyotrophic Lateral Sclerosis patients with painful muscle cramps - CMCS validation study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041156
Enrollment
30
Registered
2020-07-20
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Interventions

None listed

Sponsors

Toho University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese is the native language 2) Patients diagnosed as Possible, probable or definite,probable-laboratory-supported in El Escorial/Airlie House diagnostic criteria 3) At least 5 or more muscle cramps within 1 week 4) Can sign the consent form. 5) Over 20 years old

Exclusion criteria

Exclusion criteria: 1) Cognitive decline is suspected 2) Before taking part in this validation study , within 4 weeks the patient started taking any of the following drugs including single use, or the doses of drugs were changed, or receiving new lifestyle guidance for the purpose of prevention and treatment. including ingestion Shakuyaku-kanzo-to Baclofen Gabapentin Mexitylene Tizanidine Potassium preparation, magnesium preparation Opioid analgesics Non-steroidal anti-inflammatory drug Synthetic corticosteroids Epirizone hydrochloride Other drugs that may affect muscle cramps 3)When researchers judge inappropriate

Design outcomes

Primary

MeasureTime frame
Endpoint of CMCS 1.Trigger 2.Frequency 3.Location 4.Severity 5. Impact on everyday life

Countries

Japan

Contacts

Public ContactMASAHIRO SAWADA

Toho University Faculty of Medicine Department of Neurology "omori"

masahiro.sawada@med.toho-u.ac.jp0337624151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026